Elephas
Aaron Bergsma serves as the Director of BioPharma Services at Elephas since January 2022, where previous roles included Senior Scientist and Biopharma Services Manager. Prior experience at Thermo Fisher Scientific from June 2015 to December 2021 involved positions as Staff Scientist and Supervisor of Biochemical Screening Services, overseeing 485 unique kinase assays and leading a technical team. Earlier tenure at Life Technologies from March 2010 to June 2015 included responsibilities as Scientist III and Scientist II, focusing on troubleshooting and leading the implementation of workflows for biochemical assays. Aaron's career began at Invitrogen as Scientist I, specializing in cellular profiling. Aaron earned a Bachelor of Science in Genetics from the University of Wisconsin-Madison in 2007.
This person is not in any offices
Elephas
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodalmicroscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.